Novigenix
Series BLausanne, SwitzerlandDec 2022
Novigenix raised €20M in a Series B round in Dec 2022. The company is based in Lausanne, Switzerland. Data as of Nov 2026.
Amount raised
€20M
€20,000,000
Native amount
20,000,000 EUR
Stage
Series B
series b
Investors
0
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €20M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
0 namedNo investors disclosed for this round.
Date
Dec 2022
Round type
series b
Amount (EUR)
€20M